847
Views
27
CrossRef citations to date
0
Altmetric
Review

Diagnosis, assessment, and phenotyping of COPD: beyond FEV1

, , &
Pages 3-12 | Published online: 18 Feb 2016

References

  • HanMKAgustiACalverleyPMChronic obstructive pulmonary disease phenotypes: the future of COPDAm J Respir Crit Care Med2010182559860420522794
  • Global Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [updated 2015] Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2015_Feb18.pdfAccessed March 30, 2015
  • van der MolenTMiravitllesMKocksJWCOPD management: role of symptom assessment in routine clinical practiceInt J Chron Obstruct Pulmon Dis2013846147124143085
  • ArneMEmtnerMJansonSWilde-LarssonBCOPD patients perspectives at the time of diagnosis: a qualitative studyPrim Care Respir J200716421522117625785
  • ManninoDMSoniaBAVollmerWMChronic obstructive pulmonary disease in the older adult: what defines abnormal lung function?Thorax200762323724117090573
  • PriceDBYawnBPJonesRCImproving the differential diagnosis of chronic obstructive pulmonary disease in primary careMayo Clin Proc201085121122112921123639
  • Puente-MaestuLStringerWWHyperinflation and its management in COPDInt J Chron Obstruct Pulmon Dis20061438140018044095
  • DeesomchokAWebbKAForkertLLung hyperinflation and its reversibility in patients with airway obstruction of varying severityCOPD20107642843721166631
  • CasanovaCCoteCde TorresJPInspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2005171659159715591470
  • O’DonnellDEGuenetteJAMaltaisFWebbKADecline of resting inspiratory capacity in COPD: the impact on breathing pattern, dyspnea, and ventilatory capacity during exerciseChest2012141375376221852298
  • AgustiACalverleyPMCelliBCharacterisation of COPD heterogeneity in the ECLIPSE cohortRespir Res20101112220831787
  • Pinto-PlataVMCoteCCabralHTaylorJCelliBRThe 6-min walk distance: change over time and value as a predictor of survival in severe COPDEur Respir J2004231283314738227
  • PolkeyMISpruitMAEdwardsLDSix-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalizationAm J Respir Crit Care Med2013187438238623262518
  • BorelBProvencherSSaeyDMaltaisFResponsiveness of various exercise-testing protocols to therapeutic interventions in COPDPulm Med2013201341074823431439
  • TojoNIchiokaMChidaMMiyazatoIYoshizawaYMiyasakaNPulmonary exercise testing predicts prognosis in patients with chronic obstructive pulmonary diseaseIntern Med2005441202515704658
  • CastaldiPJSan JoseERMendozaCSDistinct quantitative computed tomography emphysema patterns are associated with physiology and function in smokersAm J Respir Crit Care Med201318891083109023980521
  • CoxsonHODirksenAEdwardsLDThe presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE studyLancet Respir Med20131212913624429093
  • CoxsonHOLeipsicJParragaGSinDDUsing pulmonary imaging to move chronic obstructive pulmonary disease beyond FEV1Am J Respir Crit Care Med2014190213514424873985
  • ParePDNaganoTCoxsonHOAirway imaging in disease: gimmick or useful tool?J Appl Physiol (1985)2012113463664622604891
  • VestboJEdwardsLDScanlonPDChanges in forced expiratory volume in 1 second over time in COPDN Engl J Med2011365131184119221991892
  • HanMKKazerooniEALynchDAChronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypesRadiology2011261127428221788524
  • MairGMillerJJMcAllisterDComputed tomographic emphysema distribution: relationship to clinical features in a cohort of smokersEur Respir J200933353654218829675
  • MairGMaclayJMillerJJAirway dimensions in COPD: relationships with clinical variablesRespir Med2010104111683169020541384
  • FishmanAMartinezFNaunheimKA randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysemaN Engl J Med2003348212059207312759479
  • WilliamsMCMurchisonJTEdwardsLDCoronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortalityThorax201469871872324473329
  • HershCPJacobsonFLGillRSilvermanEKComputed tomography phenotypes in severe, early-onset chronic obstructive pulmonary diseaseCOPD20074433133718027160
  • VestboJAgustiAWoutersEFShould we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study teamAm J Respir Crit Care Med201418991022103024552242
  • StollerJKAboussouanLSA review of alpha1-antitrypsin deficiencyAm J Respir Crit Care Med2012185324625921960536
  • MiravitllesMCalleMSoler-CatalunaJJClinical phenotypes of COPD: identification, definition and implications for guidelinesArch Bronconeumol2012483869822196477
  • HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med20103631128113820843247
  • AlbertRKConnettJBaileyWCAzithromycin for prevention of exacerbations of COPDN Engl J Med2011365868969821864166
  • LeeSJLeeSHKimYEClinical features according to the frequency of acute exacerbation in COPDTuberc Respir Dis (Seoul)201272436737323227078
  • WedzichaJABrillSEAllinsonJPDonaldsonGCMechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary diseaseBMC Med20131118123945277
  • O’DonnellDEGebkeKBActivity restriction in mild COPD: a challenging clinical problemInt J Chron Obstruct Pulmon Dis2014957758824940054
  • RaghavanNOraJWebbKAO’DonnellDE“Mild” chronic obstructive pulmonary disease – is there a case for earlier treatment?Annals of Respiratory Medicine2010112330
  • NishimuraMMakitaHNagaiKAnnual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20121851445222016444
  • BurgelPRPaillasseurJLPeeneBTwo distinct chronic obstructive pulmonary disease (COPD) phenotypes are associated with high risk of mortalityPLoS One2012712e5104823236428
  • CavaillesABrinchault-RabinGDixmierAComorbidities of COPDEur Respir Rev20132213045447524293462
  • AgustiAEdwardsLDRennardSIPersistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotypePLoS One201275e3748322624038
  • ThomsenMDahlMLangePVestboJNordestgaardBGInflammatory biomarkers and comorbidities in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20121861098298822983959
  • KimVDaveyAComellasAPClinical and computed tomographic predictors of chronic bronchitis in COPD: a cross sectional analysis of the COPDGene studyRespir Res2014155224766722
  • Izquierdo-AlonsoJLRodriguez-GonzalezmoroJMde Lucas-RamosPPrevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD)Respir Med2013107572473123419828
  • FuschilloSMartucciMDonnerCFBalzanoGAirway bacterial colonization: the missing link between COPD and cardiovascular events?Respir Med2012106791592322546638
  • KiriVASorianoJVisickGFabbriLRecent trends in lung cancer and its association with COPD: an analysis using the UK GP Research DatabasePrim Care Respir J2010191576119756330
  • BurgerCDPulmonary hypertension in COPD: a review and consideration of the role of arterial vasodilatorsCOPD20096213714419378227
  • HurdmanJCondliffeRElliotCAPulmonary hypertension in COPD: results from the ASPIRE registryEur Respir J20134161292130123018917
  • AdirYShachnerRAmirOHumbertMSevere pulmonary hypertension associated with emphysema: a new phenotype?Chest201214261654165823208339
  • ThomsenMNordestgaardBGVestboJLangePCharacteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population studyLancet Respir Med20131754355024461615
  • Global Initiative for AsthmaGlobal Strategy for Asthma Management and Prevention [updated 2015 Apr] Available from: www.ginasthma.orgAccessed May 1, 2015
  • VestboJClinical assessment of COPDHananiaNASharafkhanehACOPD: A Guide to Diagnosis and Clinical Management, Respiratory MedicineBerlin, GermanySpringer, LLC2011
  • BatemanEDHurdSSBarnesPJGlobal strategy for asthma management and prevention: GINA executive summaryEur Respir J200831114317818166595
  • BarnesPJImmunology of asthma and chronic obstructive pulmonary diseaseNat Rev Immunol20088318319218274560
  • BafadhelMMcCormickMSahaSProfiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary diseaseRespiration2012831364421912093
  • ShimizuKHasegawaMMakitaHNasuharaYKonnoSNishimuraMComparison of airway remodelling assessed by computed tomography in asthma and COPDRespir Med201110591275128321646007
  • JamesALPalmerLJKicicEDecline in lung function in the Busselton Health Study: the effects of asthma and cigarette smokingAm J Respir Crit Care Med2005171210911415486340
  • WangXMensingaTTSchoutenJPRijckenBWeissSTDeterminants of maximally attained level of pulmonary functionAm J Respir Crit Care Med2004169894194915072985
  • HaldarPPavordIDShawDECluster analysis and clinical asthma phenotypesAm J Respir Crit Care Med2008178321822418480428
  • HowrylakJAFuhlbriggeALStrunkRCZeigerRSWeissSTRabyBAClassification of childhood asthma phenotypes and long-term clinical responses to inhaled anti-inflammatory medicationsJ Allergy Clin Immunol201413351289130024892144
  • AgustiAThe path to personalised medicine in COPDThorax201469985786424781218
  • NakawahMOHawkinsCBarbandiFAsthma, chronic obstructive pulmonary disease (COPD), and the overlap syndromeJ Am Board Fam Med201326447047723833163
  • ZekiAASchivoMChanAAlbertsonTELouieSThe asthma-COPD overlap syndrome: a common clinical problem in the elderlyJ Allergy (Cairo)2011201186192622121384
  • ShayaFTDongyiDAkazawaMOBurden of concomitant asthma and COPD in a Medicaid populationChest20081341141918339789
  • SorianoJBDavisKJColemanBVisickGManninoDPrideNBThe proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United KingdomChest2003124247448112907531
  • MeyersDALarjMJLangeLGenetics of asthma and COPD. Similar results for different phenotypesChest20041262 Suppl105S110S15302770
  • HershensonMBRhinovirus-induced exacerbations of asthma and COPDScientifica (Cairo)2013201340587624278777
  • GaudeGSPulmonary manifestations of gastroesophageal reflux diseaseAnn Thorac Med20094311512319641641
  • BouletLPInfluence of comorbid conditions on asthmaEur Respir J200933489790619336592
  • ChalmersGWMacLeodKJLittleSAThomsonLJMcSharryCPThomsonNCInfluence of cigarette smoking on inhaled corticosteroid treatment in mild asthmaThorax200257322623011867826
  • ColakYAfzalSNordestgaardBGLangePCharacteristics and prognosis of never smokers and smokers with asthma in the Copenhagen general population study: a prospective cohort studyAm J Respir Crit Care Med2015192217218125914942
  • de MarcoRPesceGMarconAThe coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general populationPLoS One201385e6298523675448
  • KitaguchiYKomatsuYFujimotoKHanaokaMKuboKSputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthmaInt J Chron Obstruct Pulmon Dis2012728328922589579
  • HardinMSilvermanEKBarrRGThe clinical features of the overlap between COPD and asthmaRespir Res20111212721951550
  • FuJJGibsonPGSimpsonJLMcDonaldVMLongitudinal changes in clinical outcomes in older patients with asthma, COPD and asthma-COPD overlap syndromeRespiration2014871637424029561
  • Global Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease [updated 2014 Jan] Available from: http://www.goldcopd.com/guidelines-global-strategy-for-diagnosis-management.htmlAccessed November 12, 2014
  • AfsharKTreatment based on phenotypic variants in chronic obstructive pulmonary diseaseJ Pulm Respir Med20133e128
  • BrightlingCEMonteiroWWardRSputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trialLancet200035692401480148511081531
  • DummerJFEptonMJCowanJOPredicting corticosteroid response in chronic obstructive pulmonary disease using exhaled nitric oxideAm J Respir Crit Care Med2009180984685219661244
  • AgustiAMacNeeWThe COPD control panel: towards personalised medicine in COPDThorax201368768769023117977
  • O’DonnellDELavenezianaPThe clinical importance of dynamic lung hyperinflation in COPDCOPD20063421923217361503